Our Technology
PATENT PROTECTED HYDROGEL

Our platform technology consists of mainly two materials which have the following properties:

Shear Thinning

Inverse Thermal Gelling

Our hydrogel provides a sustained therapeutic release which out-competes other available technologies. 

 
 
 

AmacaThera

Redefining How Therapeutics Are Delivered
OUR SERVICES

About Us

AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.

Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.

We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. 

Currently, we have developed a combination product for post-operative pain, which is our company's lead project.

 Improving the lives of patients by providing sustained therapeutic release.

 
Need more details? Contact us

We are here to assist. Contact us by phone, email or via our social media channels.

 

Meet The Team

Management Team

Our  

Achievements

PARTNERSHIPS

We are actively seeking partnerships

OUR AFFILIATIONS

University of Toronto
OBIO
UTEST
MARS INNOVATION
 

© 2018 by AmacaThera

  • Black LinkedIn Icon

Follow us on